Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14109 ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Kasumi Satoh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan. Hauptthemen laut MEDLINE: Ascites. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan.
ORCID-Profile: Kasumi Satoh, Hajime Nakae
Zitieren
APA
Satoh, K., Okuyama, M., & Nakae, H. (2024). Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14109
Vancouver
Satoh K, Okuyama M, Nakae H. Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14109
BibTeX
@article{Satoh2024,
author = {Satoh, Kasumi and Okuyama, Manabu and Nakae, Hajime},
title = {Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14109}
}
EUVIMED